Lipid metabolism as a marker for glioma aggressiveness
Bioscience Reports · 17.06.2026 · 46 (6)
DOI: 10.1042/bsr20253270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 03.06.2026. Verfasst von Hennrique Taborda Ribas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Biochemistry Sciences, Sector of Biological Sciences, Federal University of Paraná, Curitiba, Brazil. Hauptthemen laut MEDLINE: Glioblastoma, Biomarkers, Tumor, Brain Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Federal University of Paraná, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most aggressive type of central nervous system tumor. There have been advances in glioma biology understanding; however, the current therapies are still inefficient. Additionally, new molecular markers are being explored for glioma grading, offering potential for novel diagnostic and drug targets. Considering the important role of lipid metabolism in tumorigenesis, understanding the lipid-related pathways in glioma could lead to new important markers. Here, lipid metabolism was analyzed by integrating two different data sources, the transcriptome data from The Cancer Genome Atlas and experimental data from tumor cells, to investigate how lipid metabolism is regulated in glioma. We compared the expression of 743 lipid-related genes in public RNAseq data of glioma patients (n = 681) to lipidomic analyses of glioblastoma cell lines (A172, U87MG, and T98G). We identified 29 lipid-related genes correlated to prognosis and constructed a risk signature based on these genes. Extracellular matrix-related genes were positively correlated to the risk score. Our findings revealed that aggressiveness is linked to alterations in membrane composition, characterized by an increase in phospholipids, coupled with a decrease in cholesterol and fatty acid unsaturation levels, which impact membrane physical properties. Modulation of critical signaling lipids, specifically sphingolipids, was also observed. Here, we identify lipid markers that may play a significant role in glioma. The converging axis involving sphingomyelinase and sphingosine-1-phosphate, mediated by the actions of sphingomyelinase SMPD1 and sphingosine-kinase SPHK1, emerged as a pivotal factor in glioma. The present study suggests that lipid membrane composition is pivotal for the GBM aggressiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Biochemistry Sciences, Sector of Biological Sciences, Federal University of Paraná, Curitiba, Brazil.
- Department of Systems Pharmacology and Translational Therapeutics (SPATT), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.
- Professional and Technological Education Sector, Federal University of Paraná, Curitiba, Paraná, Brazil.
- Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, U.S.A.
- Biochemistry and Molecular Biology Department, Sector of Biological Sciences, Federal University of Paraná, Curitiba, Brazil.
- Faculty of Science and Engineering, Department of Pharmaceutical Technology and Biopharmacy, Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, Netherlands.
ORCID-Profile: Ana Gabriela Jungles, Clementina Mesaros, Marina Trombetta-Lima
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Federal University of Paraná
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Dutch Ministry of Education, Culture and Science (OCW)
Zitieren
APA
Ribas, H. T., Ribas, G. T., Paixão de Santana-Filho, A., Jungles, A. G., Mesaros, C., Guizelini, D., Martinez, G. R., Trombetta-Lima, M., Sassaki, G. L., & Winnischofer, S. M. B. (2026). Lipid metabolism as a marker for glioma aggressiveness. Bioscience Reports, 46(6). https://doi.org/10.1042/bsr20253270
Vancouver
Ribas HT, Ribas GT, Paixão de Santana-Filho A, Jungles AG, Mesaros C, Guizelini D, et al. Lipid metabolism as a marker for glioma aggressiveness. Bioscience Reports. 2026;46(6). doi:10.1042/bsr20253270
BibTeX
@article{Ribas2026,
author = {Ribas, Hennrique Taborda and Ribas, Guilherme Taborda and Paixão de Santana-Filho, Arquimedes and Jungles, Ana Gabriela and Mesaros, Clementina and Guizelini, Dieval and Martinez, Glaucia R and Trombetta-Lima, Marina and Sassaki, Guilherme Lanzi and Winnischofer, Sheila M B},
title = {Lipid metabolism as a marker for glioma aggressiveness},
journal = {Bioscience Reports},
year = {2026},
volume = {46},
number = {6},
doi = {10.1042/bsr20253270}
}
EUVIMED